Setting Specifications of Correlated Quality Attributes through Multivariate Statistical Modelling

References

1. 1.↵
   ICH Q6B Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Product. EMEA, September, 1999.
2. 2.↵
   1. Conover W. J.

   Practical Nonparametric Statistics, 3rd ed.; Wiley: New York, 1999.
3. 3.↵
   1. Peterson J. J.

   A Bayesian approach to the ICH Q8 definition of design space. J. Biopharm. Stat. 2008, 18 (5), 959–975.

   OpenUrlPubMed
4. 4.↵
   1. Chiao C.,
   2. Hamada M.

   (2001). Analyzing experiments with correlated multiple responses. Journal of Quality Technology, 33, 451–465.

   OpenUrl
5. 5.↵
   1. Montgomery D. C.

   Introduction to Statistical Quality Control, 2nd ed.; John Wiley & Sons: New York, 1985.
6. 6.↵
   1. Eisenhart,
   2. Hastay,
   3. Wallis

   1. Hotelling H.

   Multivariate Quality Control. In Techniques of Statistical Analysis, Eisenhart, Hastay, Wallis, Eds.; McGraw-Hill, New York, 1947; pp 111–84.
7. 7.↵
   1. Hotelling H.

   A Generalized T test and Measure of Multivariate Dispersion. Proceedings of the Second Berkeley Symposium on Mathematical Statistics and Probability; University of California Press: Los Angeles and Berkeley, CA, 1951; pp 23–42.
8. 8.↵
   1. Jackson J. E.

   Quality control methods for two related variables. Industrial Quality Control 1956, XII (7), 4–8.

   OpenUrl
9. 9.↵
   1. Jackson J. E.

   Quality Control Methods for Several Related Variables. Technometrics 1959, 1 (4), 359–377.

   OpenUrlCrossRef
10. 10.↵
    1. Jackson J. E.,
    2. Bradley R. A.

    Multivariate Sequential Procedures for Testing Means. In The Development of Statistical Methods for Experimental Design in Quality Control and Surveillance Testing, Technical Report No. 10, Virginia Polytechnic Institute, 1959.
11. 11.↵
    1. Jackson J. E.,
    2. Bradley R. A.

    Sequential x2 and T2 Tests and their application to an acceptance sampling problem. Technometrics 1961, 3 (4), 519-34.

    OpenUrl
12. 12.↵
    1. Jackson J. E.,
    2. Bradley R. A.

    Sequential x2 and T2 tests. Ann. Math. Statist. 1961, 32 (4), 1063–1077.

    OpenUrl
13. 13.↵
    1. Shakun M.

    Multivariate acceptance procedures for general specification ellipsoids. Journal of American Statistical Association 1965, 60 (311), 905–913.

    OpenUrl
14. 14.↵
    1. Jenkins G. I.

    Multivariate methods applied to product testing and specifications. Journal of the Royal Statistical Society. Series D (The Statistician) 1967, 17 (2), 141–155.

    OpenUrl
15. 15.↵
    1. Hopke P. K.

    Receptor Modeling for Air Quality Management. Elsevier: Amsterdam, Oxford, New York, Tokyo, 1991.
16. 16.↵
    1. Tsong Y.,
    2. Hammerstrom T.,
    3. Sathe P.,
    4. Shah V. P.

    Statistical assessment of mean differences between two dissolution data sets. Drug Information Journal 1996, 30 (4), 1105–1112.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Polli J. E.,
    2. Rekhi G. S.,
    3. Shah V.

    Methods to compare dissolution profiles. Drug Information Journal 1996, 30 (4), 1113–1120.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Sathe P. M.,
    2. Tsong Y.,
    3. Shah V. P.

    In vitro dissolution profile comparison: statistics and analysis, model dependent approach. Pharm. Res. 1996, 13 (12), 1799–1803.

    OpenUrlPubMed
19. 19.↵
    1. Polli J. E.,
    2. Rekhi G. S.,
    3. Augsburger L. L.,
    4. Shah V. P

    Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J. Pharm. Sci. 1996, 86 (6), 690–700.

    OpenUrl
20. 20.↵
    1. Tsong Y.,
    2. Hammerstrom T.,
    3. Chen J. J.

    Multipoint dissolution specification and acceptance sampling rule based on profile modeling and principal component analysis. J. Biopharm. Stat. 1997, 7 (3), 423–439.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Shah V. P.,
    2. Tsong Y.,
    3. Sathe P.,
    4. Liu J.-P.

    In vitro dissolution profile comparison—statistics and analysis of the similarity factor, f2. Pharm. Res. 1998, 15 (6), 889–896.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Chow S.-C.

    1. Tsong Y.,
    2. Sathe P. M.,
    3. Shah V. P

    In Vitro Dissolution Profile Comparison. In Encyclopedia of Biopharmaceutical Statistics, 2nd ed.; Chow S.-C., Ed.; Marcel Dekker: New York, 2003; pp 456–462.
23. 23.↵
    1. Yang H.,
    2. Zhao W.,
    3. O'Day T.,
    4. Fleming W.

    Environmental monitoring: setting alert and action limits based on a zero-inflated model. PDA J. Pharm. Sci. Technol. 2013, 67 (1), 1–9.

    OpenUrlFREE Full Text
24. 24.↵
    1. Jiang XR.,
    2. Song A.,
    3. Bergelson S.,
    4. Arroll T.,
    5. Parekh B.,
    6. May K.,
    7. Chung S.,
    8. Strouse R.,
    9. Mire-Sluis A.,
    10. Schenerman M.

    Advances in the assessment and control of the effector functions of therapeutic antibodies. Nat. Rev. Drug Discov. 2011, 10 (2), 101–110.

    OpenUrlCrossRefPubMed
25. 25.↵
    FDA Guidance for Industry: Statistical Approaches to Establishing Bioequivalence. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), January 2001.
26. 26.↵
    1. Lehmann E. L.,
    2. Casella G.

    Theory of Point Estimation, 2nd ed.; Springer-Verlag New York, Inc.: New York, 1998.
27. 27.↵
    1. Chow S.-C.,
    2. Liu J. P.

    Design and Analysis of Bioavailability and Bioequivalence Studies. Marcel Dekker, Inc.: New York, Basel, Hong Kong, 1992.
28. 28.↵
    1. Rowland M.,
    2. Tozer T. N.

    Clinical Pharmacokinetics Concepts and Applications, 3rd ed.; Williams & Wilkins: Philadelphia, PA, 1995.
29. 29.↵
    U.S. FDA. Pharmaceutical cGMPs for the 21^st Century: A Risk-based Approach: Final Report, 2004.
30. 30.↵
    ICH Q8 (R2). Pharmaceutical Development, 2006.
31. 31.↵
    ICH Q9. Quality Risk Management, 2007.
32. 32.↵
    ICH Q10. Pharmaceutical Quality Systems, 2007.
33. 33.↵
    ICH Q11. Concept Paper, 2011.
34. 34.↵
    FDA PAT Guidance for Industry: A Framework for Innovative Pharmaceutical Development, Manufacturing and Quality Assurance, September 2004.